University of Michigan at Antibody Engineering 2026

Dec 13–16, 2026 San Diego, CA ~900 attendees Website

University of Michigan takes part in 2 sessions at Antibody Engineering 2026 in San Diego. Its program covers how to pick drug candidates that will be easy to develop, and uses of antibodies beyond cancer. Its research uses dual-targeted carriers called oligoshuttles that lower gene activity in nerve cells after being given outside the nervous system.

OrganizationAntibody Engineering 2026 Attendance
Academic
Public research university in Ann Arbor, Michigan.
Chair
Sun Dec 13
1:00pm–1:15pm
Co-Chairs’ Remarks- Engineering Considerations for Candidate Selection and Developability
Workshop 2: Engineering Considerations for Candidate Selection and Developability · with Atlas Venture NewCo
Talk
Tue Dec 15
3:00pm–3:30pm
Dual-targeted Oligoshuttles Mediate Efficient Reduction of Neuronal Gene Expression after Peripheral Administration
Antibodies that grab two receptors to cross into the brain and deliver gene-silencing strands into nerve cells.
Bispecifics & multispecifics

Explore the full Antibody Engineering 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full Antibody Engineering 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Michigan

Tell us what you sell and we’ll find the people at University of Michigan most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction